Benthic marine invertebrates collected from sub-Arctic regions of northern Norway, 18 were found to be a promising source of novel bioactive compounds against human and fish 19 pathogenic bacteria and fungi. Lyophilized material from seven species of ascidians, six 20 sponges and one soft alcyonid coral were extracted with 60% acidified acetonitrile (ACN). 21
(salt-rich) phase. This separation is caused be the high salt content in the invertebrate tissues, 5 which is immiscible with ACN. After separation of the two phases and lyophilisation, the 6 ACN-extract was stored at -20 o C until activity screening was performed, while the remaining 7 pellet of insoluble material was discarded. The aqueous phase was dissolved in Milli-Q water 8 to a concentration of 100 mg/ml. To avoid false positives during antimicrobial testing, salts 9
were removed from the aqueous phase by solid-phase extraction (SPE), as described by Haug 10 et al. (2002) . Briefly, the aqueous phase was loaded onto Sep-Pak C18 Vac cartridges (Waters) 11 equilibrated in acidified Milli-Q water (0.05% TFA). After washing with acidified water, 12 three stepwise elutions were performed with acidified solutions of 10%, 40%, and 80% ACN 13 in Milli-Q water (v/v) (containing 0.05% TFA). Non-bound material was discarded. The 14 isolated SPE-fractions from the aqueous phase were lyophilized and kept frozen at -20 o C 15 until bioactivity screening was performed. Figure 1 gives a summary of the extraction and 16 purification procedures employed in the study. 17 18
Antibacterial assay 19 20
The Gram-negative bacteria Listonella anguillarum, serotype O2 (FT 1801, a fish 21 pathogenic strain), Escherichia coli (ATCC 25922), and the Gram-positive bacteria 22
Staphylococcus aureus (ATCC 9144) and Corynebacterium glutamicum (ATCC 13032) were 23 used as test organisms. All isolates were grown at room temperature (18-20 o C) in Muellerextracts were diluted in Milli-Q water to a concentration of 10 mg/ml and serial two-fold 1 compared to single wavelength detection. Cecropin B (25 M), an antimicrobial peptide 11 originally isolated from the silk moth Hyalophora cecropia, was synthesized as described bydextrose agar with 2% glucose at room temperature. Fungal spores were dissolved in potato 23 dextrose broth (Difco) and the cell concentration was determined and adjusted after counting 24 in a Bürker chamber. An aliquot of 50 µl of fungal spores (final concentration 2 x 10 5 25 spores/ml) were inoculated in 96-well nunc TM microtitre plates along with 50 µl of the SPE-1 fractions or ACN-extracts which were dissolved in Milli-Q water. The SPE-fractions and 2 ACN-extracts were tested at final concentrations (prepared from serial two-fold dilutions) 3 ranging from 5 to 0.02 mg/ml. Cultures were grown in a moist dark chamber without shaking 4 at 20 °C for S. cerevisiae and at 37 °C for C. albicans. Synthetic cecropin B was used as a 5 positive control (3.12 againstS. cerevisiae and 6.25 against C. albicans). Growth 6 inhibition was determined microscopically after 48 h of incubation. MIC (minimal inhibitory 7 concentration) was set as the lowest concentration of sample resulting in more than 50% 8 inhibition of visible growth compared to the growth control (fungal spores plus water). 9
Fractions that were active at concentrations of 0.08 mg/ml were considered to possess high 10 activity. Tables 1 and 2 show the results from the in vitro antibacterial and antifungal screening 3 of 56 fractions/extracts from seven ascidians, six sponges and one soft alcyonid coral 4 collected off the coast of northern Norway. All species tested yielded fractions showing 5 activity against both bacteria and fungi. Overall, the aqueous fractions (especially the 40% 6 and 80% SPE-fractions) displayed highest antimicrobial activity. Furthermore, the Gram-7 positive bacterial test strains were in general the most sensitive microorganisms (Table 3) . 8
. 9
Antibacterial and antifungal activity in ascidians 10

11
Seven species of ascidians were investigated for antibacterial activity (Table 1) . A 12 total of 23 fractions (including SPE-fractions and ACN-extracts), including SPE-fractions and 13 against L. anguillarum. Among the ascidians, the highest activity against the Gram-negative 18 bacteria were obtained in the 40% and 80% SPE-fractions from C. intestinalis and the 80% 19 SPE-fraction from S. pulmonaria and D. aggregata. Notably, most of the more lipophilic 20 ACN-extracts from the ascidians showed no antibacterial activity against the Gram-negative 21
bacteria within the concentration range tested. The only exceptions being the ACN-extracts 22 from S. pulmonaria, D. aggregata and A. virignea, in which the extract from S. pulmonaria 23 was the overall most potent ACN-extract obtained against the Gram-negative bacteria with anOverall, the SPE-fractions from the ascidians exhibited a higher potency against the 1 Gram-positive bacteria than against the Gram-negative bacteria, and as expected C. 2 glutamicum was more susceptible than S. aureus (Table 1) . A total of 25 fractions displayed 3 activity against the Gram-positive bacteria, and 11 fractions displayed high activity (Table 3) . 4
The 40% and 80% SPE-fractions of S. pulmonaria, C. intestinalis, D. aggregata and S. 5 rustica, as well as the 10% SPE-fractions of D. aggregata and the 40% SPE-fraction of A. 6 virginea, all gave high activity against the Gram-positive bacteria. Except for the ACN-7 extracts of S. rustica and H. pyriformis, all the more lipophilic ACN-extracts showed 8 antibacterial activity. 9
As observed against the Gram-negative bacteria, the most potent SPE-fractions and 10 ACN-extracts were obtained from the colonial ascidian S. pulmonaria. Notably, the ACN-11 extract inhibited growth of all the Gram-negative and Gram-positive bacteria at a 12 concentration of 0.02 mg/ml (Table 1 ). Fig. 2 shows the time course study of the antibacterial 13 effect of the ACN-extract at the three lowest concentrations tested, and illustrates the high 14 efficiency of this extract, as no bacterial growth is detected. 15
In addition to antibacterial activity, we also screened the SPE-fractions and ACN-16 extracts for antifungal activity. Notably, we detected in vitro antifungal activity in all ascidian 17 species tested, and S. cerevisiae was in general more susceptible than C. albicans (Table 1) . 18
The SPE-fractions and the ACN-extracts showing high activity against bacteria also exhibited 19 high activity against fungi, although the overall potency against fungi was lower than against 20 bacteria. The ACN-extract from S. pulmonaria showed high activity against C. albicans and S. 21 cerevisiae (Fig. 3) . Similarly to the antibacterial results, the 40% and 80% SPE-fractionspossessed the highest potencies. The 40% and 80% SPE-fractions of C. parallelogramma 23 were the only fractions that exhibited higher activity against fungi than bacteria. As observed for the ascidians and the sponges, the soft alcyonid coral showed higher 7 activity against Gram-positive bacteria than Gram-negative bacteria, where it exhibited 8 activity at a concentration of 0.08 mg/ml (Table 2) . Antifungal activity was observed in all the 9 SPE-fractions of A. digitatum. The colonial ascidian species S. pulmonaria gave the highest activities detected 3 against both bacteria and fungi, and at a concentration of 0.02 mg/ml. This was the lowest 4 concentration tested in the study, indicating that the potency was possibly higher. It is 5 interesting that the ACN-extract of S. pulmonaria gave strong activity when there was 6 generally low activity in the ACN-extracts of the other organisms tested, suggesting that more 7 lipophilic components might be responsible for the activity observed. Antibacterial and 8
antifungal activities have to our knowledge not been reported in S. pulmonaria previously. 9
The 40% and 80% SPE-fractions of the ascidian C. intestinalis, had high activities 10 against both bacteria and fungi. It is noteworthy that two antimicrobial peptides, an 8-15 kDa 11 peptide active against marine Gram-positive bacteria, and a 60-70 kDa protein, active against 12 both marine Gram-positive and Gram-negative bacteria, have been isolated from the blood 13 cells of C. intestinalis (Findlay and Smith, 1995) . Fedders and Liepe (2008) recently 14 confirmed these findings, however, they were unable to identify the peptides structurally by 15 N-terminal protein sequencing and mass spectrometric methods due to an unfortunate 16 combination of post-translational modifications, subspecies differences and low abundance 17 (Fedders and Leippe, 2008) . However, using genomic data they identified a putative gene 18 family exhibiting features typical of antimicrobial peptides and synthesized a peptide based 19 on these data which showed activity against both Gram-negative and Gram-positive bacteria 20 (Fedders and Leippe, 2008 ). An additional synthetic peptide, M4F19, showing antimicrobial 21 activity, has been prepared based on a putative antimicrobial precursor peptide, identified in 22 the blood cells of C. intestinalis (Jang et al., 2005) . Whether the antibacterial activity detected 23 in the present study is caused by antimicrobial peptides or other compounds remains to be 24 clarified. Antifungal activity has been reported for C. intestinalis in the form oftribromophenol, which is a known fungicide (Kotterman et al., 2003) . In the former study, C. 1 intestinalis was collected from a recirculation system in the Netherlands and extracted with a 2 relatively lipophilic mixture of hexane/acetone (3:1) (Kotterman et al., 2003) . The antifungal 3 activity detected in the aqueous SPE-fractions in the present study might therefore be caused 4 by other, more hydrophilic compounds. 5
Antibacterial activity has previously been detected in methanol/dichloromethane 6 extracts of the ascidians H. pyriformis and a mixture of two Styela species where one of the 7 species was S. rustica (Lippert et al., 2003) . The species in the study by Lippert et al. (2003) 8 were collected in Spitsbergen, Norway, which is located about 10 o north of where the species 9 in our project were collected. Interestingly, they screened 18 invertebrate species (including 10 ascidians, sponges and bryozoa), but only 7 species showed antibacterial activity. Lippert et al 11 (2003) suggested that only a minor portion of Arctic invertebrates possess antibacterial 12 activity compared to species from lower latitudes, as well as those from Antarctica. This 13 statement is strongly contradicted by the findings in the present study where all species 14 screened displayed antibacterial activity. However, the difference in the incidence of activity 15 may be due to differences in methods of extraction, bacterial strains tested, etc. To our 16 knowledge, antibacterial and antifungal activities have previously not been reported for the 17 other cold-water ascidians investigated in the current project. 18
The sponge G. barretti, collected from the coast of Sweden, has previously been 19 shown to possess activity against E. coli and S. aureus (Andersson et al., 1983) . The activity 20 was detected in a water and a petroleum ether extract. Two antifouling cyclopeptides, barettin 21 and 8,9-dihydrobarettin, were later isolated from G. barretti by the same research group 22 (Sjogren et al., 2004) . These compounds might be responsible for the antimicrobial activities 23 detected in the present study.
There are some reports of antibacterial activity in the sponge genera Haliclona 1 collected from cold water regions. These include extracts of the sponge H. viscosa collected 2 from Spitsbergen, Norway, in the study by Lippert et al (2003) . In later work, Volk and Kock 3 (2004) structurally characterized an antimicrobial compound isolated from an n-butanol 4 extract of the same species, collected from the same area of Norway. An aqueous extract of H. 5 rosea (from the Mediterranean) was shown to be active against E. coli, whereas methanol and 6 acetone extracts had no activity (Nigrelli et al., 1967) . Lippert et al. (2003) also investigated 7 antimicrobial activity in H. rosea, but detected no antimicrobial activity. However, this may 8 be due to different strains of test-bacteria and/or different experimental procedures. 9
Antifungal compounds have also been previously isolated from Haliclona species. Ansponge, P. boletiformis, was found to be active against various human pathogens including S. 18 aureus and C. albicans (Kong and Anderssen, 1993) . 19
Ethanol extracts of the sponge M. incrustans, collected off the coast of Mexico, 20 displayed no antibacterial and antifungal activity (Encarnacion et al., 2000) . This is in 21 contradiction to the findings in the current work where M. incrustans displayed activity 22 against both bacteria and fungi. It is worth pointing out that we can not exclude symbiotic 23 microorganisms as the source of the active compounds instead of the invertebrate species 24 themselves. For instance, a fungal strain isolated from M. incrustans has been shown to 1 produce numerous antimicrobial compounds (Holler et al, 1999) . 2
In the present study, the soft alcyonid coral A. digitatum displayed potent 3 antimicrobial activity against both bacteria and fungi. Activity against S. aureus has 4 previously been reported in the water extract of A. digitatum (Andersson et al., 1983) .
Many antimicrobial screening studies have shown that Gram-positive bacteria are 1 more sensitive than Gram-negative bacteria and fungi to extracts of sponges and ascidians 2 (Amade et al., 1987; McCaffrey and Endean, 1985; Rinehart et al., 1984) . In fact, out of 777 3 species of sponges collected from the Caribbean Sea, 35% had activity against Gram-positive 4 bacteria, 15% had activity against Gram-negative bacteria, and 10% had activity againstmore lipophilic 40% and 80% SPE-fractions, were generally more potent against both bacteria 
